Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Try the new Yahoo Finance
Advertisement
U.S. markets open in 1 hour 10 minutes
S&P Futures
5,875.75
-20.50
(-0.35%)
Dow Futures
43,045.00
-132.00
(-0.31%)
Nasdaq Futures
20,438.25
-81.25
(-0.40%)
Russell 2000 Futures
2,244.90
-10.60
(-0.47%)
Crude Oil
71.23
+0.67
(+0.95%)
Gold
2,747.70
+8.80
(+0.32%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
8.47
-0.11
(-1.28%)
At close: 04:00PM EDT
8.62
+0.15
(+1.77%)
After hours:
05:51PM EDT
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
Expand All
All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,597,992
2,393,607
2,212,304
2,093,669
1,992,523
-
Cost of Revenue
1,687,627
1,573,042
1,427,596
1,324,696
1,364,130
-
Gross Profit
910,365
820,565
784,708
768,973
628,393
-
Operating Expense
631,503
596,315
595,786
575,067
517,312
-
Operating Income
278,862
224,250
188,922
193,906
111,081
-
Net Non Operating Interest Income Expense
-282,684
-251,434
-158,668
-136,325
-145,998
-
Other Income Expense
-111,799
-13,086
-278,381
-26,215
-863
-
Pretax Income
-115,621
-40,270
-248,127
31,366
-35,780
-
Tax Provision
17,581
8,452
6,662
11,196
-104,358
-
Net Income Common Stockholders
-174,616
-83,993
-129,986
10,624
91,059
-
Diluted NI Available to Com Stockholders
-174,616
-83,993
-129,986
10,624
91,059
-
Basic EPS
0.07
-0.48
-0.86
0.07
0.62
-
Diluted EPS
0.06
-0.48
-0.86
0.07
0.61
-
Basic Average Shares
152,893
176,136
150,944
148,922
147,443
-
Diluted Average Shares
155,083
176,136
150,944
151,821
148,913
-
Total Operating Income as Reported
174,565
204,374
-94,928
152,716
91,155
-
Total Expenses
2,319,130
2,169,357
2,023,382
1,899,763
1,881,442
-
Net Income from Continuing & Discontinued Operation
-174,616
-83,993
-129,986
10,624
91,059
-
Normalized Income
-79,367
-69,611
104,023
37,337
93,580
-
Interest Expense
241,879
210,629
158,377
136,325
145,998
-
Net Interest Income
-282,684
-251,434
-158,668
-136,325
-145,998
-
EBIT
126,258
170,359
-89,750
167,691
110,218
-
EBITDA
351,497
399,759
150,425
401,097
345,605
-
Reconciled Cost of Revenue
1,687,627
1,573,042
1,427,596
1,324,696
1,364,130
-
Reconciled Depreciation
225,239
229,400
240,175
233,406
235,387
-
Net Income from Continuing Operation Net Minority Interest
-174,616
-83,993
-129,986
10,624
91,059
-
Total Unusual Items Excluding Goodwill
-120,568
-18,205
-296,214
-41,545
-3,453
-
Total Unusual Items
-120,568
-18,205
-296,214
-41,545
-3,453
-
Normalized EBITDA
472,065
417,964
446,639
442,642
349,058
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-25,319
-3,823
-62,205
-14,832
-932.31
-
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy controls
WA Consumer Health Privacy Policy
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.